Aging
Navigate
Back to articleFigure 2(2 of 6)
100%
Figure 2
Figure 2.Survival analyses of KIF14 in LUAD. (AF) K-M plots for OS in different LUAD cohorts (TCGA-LUAD cohort, Harvard -LC cohort, jacob-00182-MSK cohort, GSE13212 cohort, GSE31210-1 cohort, and GSE31210-2 cohort). (GI) Survival curves of PFS, RFS in LUAD cohorts (TCGA-LUAD cohort, GSE31210-1 cohort, and GSE31210-2 cohort). (JL) OS survival analyses of KIF14 in LUAD cohorts with negative results (jacob-00182-CANDF cohort, jacob-00182-UM cohort and jacob-00182-HLM cohort). (M, N) Univariate (M) and multivariate (N) Cox regression analyses to evaluate the independent factors of KIF14 in TCGA-LUAD cohort.
Figure 2 — Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma | Aging